In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

Tharimmune, Inc., (Nasdaq:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology announced ...

The 13th annual Scholars Symposium was held today at the University of Maine Fort Kent. The theme of this years event was ...